AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06291506 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation of heart atrial tissue.
Description: Ablation with radiofrequency, advances techniques: contact force-guided, improved tissue temperature sensors, automark algorithms.
Study NCT06291506 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency ablation of heart atrial tissue.
Description: Ablation with radiofrequency, advances techniques: contact force-guided, improved tissue temperature sensors, automark algorithms.
Study NCT05220371 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Collagen
Description: Participants ingest 15 grams of either specific collagen peptides or Placebo daily
Study NCT05220371 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concurrent training
Description: Both arms undergo a 12-week trainingintervention 3x/week
Study NCT05220371 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Concurrent training
Description: Both arms undergo a 12-week trainingintervention 3x/week
Study NCT05471206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Milk and SmartPill intakes
Description: During visit V2, the subject will ingest the SmartPill capsule. Then, subjects will drink milk.
Study NCT05471206 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Milk and SmartPill intakes
Description: During visit V2, the subject will ingest the SmartPill capsule. Then, subjects will drink milk.
Study NCT05730374 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Benson's Relaxation technique
Description: Each child in the study group had an individual interview with researchers, who demonstrated the Benson relaxation technique while teaching them. The child was then asked to demonstrate it. sit quietly in a comfortable position in separate room., close eyes, deeply relax all muscles, beginning at the feet and progressing up to the face and breathe through nose. Become aware of breathing pattern. As breathes out, say the word one silently to child. For example, breathe in, and then out, say one, in and out, and repeat one. Breathe easily and naturally. It is Continue for 10 minutes and repeated two times.
Study NCT05730374 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: * The child lessen to a Mozart's music, which is played before and throughout the blood transfusion procedure. Ambient noise can be reduced by using headphones. As a result, it is easier to see how the intervention has succeeded.~* This intervention was done using an MP3 player during the blood transfusion procedure and immediately following the completion of the intervention to prevent the transmission of infections headphones were cleaned with disinfectant after each -use.
Study NCT02942706 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: anti-EGFR monoclonal antibody
Study NCT02942706 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: anti-EGFR monoclonal antibody
Study NCT02942706 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mFOLFOX6
Description: Oxaliplatin+LV5FU2
Study NCT02942706 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI
Description: Irinotecan+LV5FU2
Study NCT04944381 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-Cov-2 mRNA vaccine immunization
Description: The 98 participants will be inoculated with one dose SARS-Cov-2 mRNA vaccine from Stemirna Therapeutics Co., Ltd and .
Study NCT04944381 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-Cov-2 vaccine immunization
Description: The 14 participants will be inoculated with one dose inactivated SARS-Cov-2 vaccine from institute of medical biology, Chinese academy of medical sciences(IMBCAMS).
Study NCT05165550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elsulfavirine
Description: Elsulfavirine (Elpida®) 20 mg capsules for oral administration
Study NCT06409117 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention
Description: Percutaneous coronary intervention with scaffold implantation in patients with NSTE/ACS
Study NCT05156944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physiotherapeutic intervention
Description: The intervention consists of a brief physiotherapeutic assessment, the short physical performance battery, a brief information on the expected course of the condition, a check of fall hazards at home using the Bundesamt für Unfallverhütung (bfu) checklist, and instructions on self-management (eg. staying active, adaptation of behavior and surrounding at home). Additionally, two exercises for daily self-guided therapy will be instructed, namely, sit-to-stand and balance performance exercises.
Study NCT05604144 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Cryoanalgesia (iovera°®)
Description: iovera°® treatment will be administered via ultrasound guidance to 1-2 branches of the dorsal/digital/proper nerve/s that innervate the Morton's neuroma. The treatment will be completed one time per subject.
Study NCT06069180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan
Description: Conditioning regimens were Bu/Flu/Cy/ATG or Bu/Cy/ATG, depending on the patient's risk factors of regimen related cardiotoxicity.
Study NCT06069180 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Flu/Cy/ATG or Cy/ATG
Description: Conditioning regimens were Flu/Cy/ATG or Cy/ATG, depending on the patient's risk factors of regimen related cardiotoxicity.
Study NCT06199908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMT-562
Description: Administered AMT-562 for injection intravenously
Study NCT06000930 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Troponin fragmentation
Description: laboratory test from blood sample
Study NCT05265481 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tourniquet
Description: The investigators will apply a pressure cuff tourniquet inflated to 60 mmHg
Study NCT05265481 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tourniquet
Description: The investigators will apply a pressure cuff tourniquet inflated to 60 mmHg
Study NCT05265481 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Manual Tapping
Description: The investigators will apply tapping directly over the vein manually to increase the vein dimension.
Study NCT05265481 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device tapping
Description: The investigators will apply tapping directly over the vein with a massage device to increase the vein dimension.
Study NCT05684588 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Magnetic Resonance
Description: After enrollment a Magnetic Resonance without medium contrast, at 1 year from previous hospitalization
Study NCT04645823 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Citrate
Description: Fentanyl citrate 20 µg in 2 ml of saline injected into csf
Study NCT05302895 — intervention group
Intervention type: DEVICE
Intervention: All-in-one health monitoring device
Description: The staff will use the new monitoring device to carry out the health monitoring on every day during the 12-week period. After each round of health monitoring by the traditional and the new devices, the staff will need to fill in log sheets designed by HKU to document the time consumed for the entire process.
Study NCT06084000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
Description: * Patients treated with DCB will receive dual antiplatelet therapy (DAPT, aspirin plus P2Y12 inhibitor) for 1-3 months, followed by long-term single antiplatelet therapy (SAPT, aspirin or P2Y12 inhibitor).~* Patients with bailout stenting will generally receive DAPT for 6 months unless deemed as with high ischemic and/or bleeding risks (see special consideration in Drug-eluting stent Arm), and then followed by long-term SAPT.
Study NCT06084000 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Drug-eluting stent
Description: * Patients treated with DES will generally receive DAPT for 6 months unless deemed as with high ischemic and/or bleeding risks (see special consideration below), and then followed by long-term SAPT.~* Special consideration:~  1. Patients will take additional assessment (both DAPT score and PRECISE-DAPT score) to determine their personalized duration of DAPT.~ 2. The duration of DAPT is extended to 12 months for patients diagnosed as acute coronary syndrome within 12 months.~ 3. If anticoagulation is indicated, patient will receive a short-term triple antithrombotic therapy (generally 1 to 4 weeks), followed by a variable length of dual antithrombotic therapy (oral anticoagulation (OAC) plus a single antiplatelet agent, preferably clopidogrel) and subsequent long-term OAC mono-therapy. The duration of dual antithrombotic therapy is determined by bleeding risks (HAS-BLED score) according to current guidelines.
Study NCT04645823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% Injectable Solution
Description: Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume
Study NCT04645823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl Citrate
Description: Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume
Study NCT04754113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prone position
Description: patient was helped into the prone position, patient received instructions of end expiratory occlusion lasting at least 10 seconds and, 1 seconds after the start, a bolus of 10 mL of 5% NaCl solution was injected via the central venous catheter
Study NCT06312605 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Injectable applied vitamin C
Description: Surgical gingival depigmentation is done for all participants, after then they receive injectable vitamin C
Study NCT06312605 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Topical applied Vitamin C
Description: Surgical gingival depigmentation is done for all participants, after then they are instructed to apply topical vitamin C
Study NCT06312605 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgical depigmentation only
Description: Surgical gingival depigmentation only without any drug
Study NCT05072756 — intervention group
Intervention type: OTHER
Intervention: Applying a questionnaire
Description: The participants have to answer a questionnaire addressing their opinion on menopausal hormone replacement therapy
Study NCT04714489 — intervention group
Intervention type: OTHER
Intervention: NO.
Description: NO.
Study NCT06161857 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention this is an observational study to develop a diagnostic test
Study NCT06094972 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adolescent Community Reinforcement Approach, A-CRA
Description: A-CRA consists of eighteen treatment modules/procedures that is delivered in weekly sessions over 12-14 weeks. The overarching goal is to decrease substance use behaviours and other related, problematic behaviours such as acting out when experiencing anger, and to increase prosocial and sober behaviours, relationships and activities. The procedures are: 1) Introduction to A-CRA/treatment agreement, 2) Happiness scale and treatment goals, 3) Homework, 4) Systematic encouragement, 5) Functional analysis of substance use behaviour, 6) Functional analysis of prosocial/sober behaviour, 7) Increasing prosocial activities, 8) Drink/drug refusal, 9) Relapse prevention, 10) Sobriety sampling, 11) Communication skills, 12) Problem-solving, 13) Caregiver sessions, 14) Relationship skills, 15) Couple relationship skills, 16) Job-seeking skills, 17) Anger management, 18) Medication adherence and monitoring. Youths' individual goals and problems guide treatment planning.
Study NCT06094972 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Standard care is defined as the interventions and treatments adolescents are usually offered and undergo in institutional care in Sweden. These are Motivational Interviewing, MI, Cognitive Behavioral Therapy, CBT, Aggression Replacement Therapy, ART or Acceptance and Commitment Therapy, ACT and PULS, a program for reducing violence and criminal behavior. Also, individually tailored interventions will be included, such as counselling or other psychological interventions. TAU will be thoroughly registered during the study since the sites in the trial differs slightly in what they offer.
Study NCT06415162 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cooling Pillowcases
Description: No intervention will be given to the patients in the control group.
Study NCT06308146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis ATCC 122264
Description: One capsule (5 billion CFU) per day for 8 weeks.
Study NCT06308146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One capsule per day for 8 weeks.
Study NCT05564676 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: flaxseed oil and pomegranate dry extract
Description: The flaxseed oil were yellow capsules with 1.0 g each and the pomegranate dry extract capsules were green with 0.6 g each.
Study NCT05564676 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: sunflower oil and microcrystalline cellulose
Description: The sunflower oil were yellow capsules with 1.0 g each and the microcrystalline cellulose capsules were green with 0.6 g each.
Study NCT05688293 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue graft
Description: non-surgical periodontal treatment and connective tissue graft
Study NCT05688293 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Free gingival graft
Description: will receive non-surgical periodontal treatment and partially de-epithelized free gingival graft
Study NCT05688293 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non surgical
Description: non-surgical periodontal treatment only
Study NCT05151367 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text message reminder
Description: Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)
Study NCT04323423 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interrupting sedentary behaviour with light physical activity
Description: replacing sitting with light walking bouts at different frequencies/durations
Study NCT04985240 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lettuce with no biofortification
Description: Lettuce without any biofortification was assigned to each participant belonging to the control group which ate 100gr every day for 10 days
Study NCT04985240 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Intervention Molibdenum group
Description: Lettuce with Iodine biofortification was assigned to each participant belonging to the intervention group which ate 100gr every day for 10 days
Study NCT05474469 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diaphragmatic breathing exercises
Description: 12 treatment sessions for 4 weeks period, which consisted of 03 treatment sessions per week.
Study NCT05474469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercises
Description: 12 treatment sessions for 4 weeks period, which consisted of 03 treatment sessions per week.
Study NCT05474469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal muscle strengthening exercises
Description: 12 treatment sessions for 4 weeks period, which consisted of 03 treatment sessions per week.
Study NCT05849896 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acquisition of HD sEMG signals using the WPM-SEMG device
Description: The WPM-SEMG-V2 device will be placed over the muscle of the participant to be investigated. A reference electrode over a bone close to the muscle of investigation will be applied. A sensor combing an accelerometer, gyroscope and magnetometer integrated in the WPM-SEMG-V2 device will be also used for the acquisition of body movement measures. An additional component for trapezoidal force measurement will be used during the acquisition in static contractions to measure the force. The participant will be instructed by the investigator how to execute the static or the dynamic exercises. Visual feedback will help the subject to track the trajectory.
Study NCT05276765 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cad/cam socket sealing abutment
Description: Anatomically formed healing abutments that can solve many of the problems inherent to immediate posterior implant placement and to optimize the conditioning of supra implant tissue architecture enhancing the emergence profile of the final implant restoration
Study NCT05276765 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: standard healing abutment
Description: Standard healing abutment will be inserted after removal of cover screw after immediate implant insertion and then a muco-periosteal flap will be reflected for the primary closure of the socket and sutured around the standard healing abutment.
Study NCT05559073 — intervention group
Intervention type: PROCEDURE
Intervention: Radiofrequency ablation
Description: pulmonary vein isolation using radiofrequency ablation.
Study NCT05211609 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Plasmatic 3-O-Methyldopa dosage
Description: Plasmatic 3-O-Methyldopa dosage
Study NCT06288633 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ganglionated plexi ablation
Description: Through access in the femoral vein, a mapping or ablation-mapping catheter is inserted into the right atrium, and a three-dimensional reconstruction of the right atrium is performed using an electroanatomic mapping system. The inferior and superior vena cava, the coronary sinus are indicated.~Then a transeptal puncture is performed using a transeptal introducer and a needle for transeptal puncture under fluoroscopic control. A three-dimensional reconstruction of the left atrium is performed using an electroanatomic mapping system.~During or immediately after the creation of three-dimensional maps of both atria, areas of the typical concentration of ganglion plexuses (GP) are ablated using radiofrequency applications (30-50 Watts, 10-40 s each point). Ablated points are annotated on the three-dimensional map. GPs ablation zones are about 0.5 x 1.0 cm in size.
Study NCT05340543 — intervention group
Intervention type: PROCEDURE
Intervention: Confocal optical coherence tomography - OCTAVE
Description: An ex vivo examination of cutaneous resection with the OCTAV® prototype integrating the dermoscope function
Study NCT06151496 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alpha-Agonist
Description: The maternal systolic blood pressure was consistently maintained above 80% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.
Study NCT06151496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: α-adrenergic receptor agonist
Description: The maternal systolic blood pressure was consistently maintained above 90% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.
Study NCT05199168 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: intraoperative nerve monitoring
Description: Intraoperative bilateral recurrent laryngeal nerve monitoring was utilized during dissection of right and left recurrent laryngeal nerve lymph nodes.
Study NCT06288633 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Electrophysiological study
Description: Through access in the femoral vein, a diagnostic catheter is inserted in the area of the coronary sinus under fluoroscopic control. The effective refractory period (ERP) of the atria will be measured according to the method adopted in clinical practice, namely: using a ten-pole diagnostic electrode installed in the coronary sinus, a series of eight electrical pulses with the same amplitude and frequency is applied to the atrial myocardium. Then the ninth pulse is applied with a gradual decrease in the time interval until the absence of an atrial myocardium response to the pulse is registered. The cycle of an additional, ninth pulse, in which the atrial myocardium did not respond to an electrical impulse, is considered an atrial ERP.
Study NCT05433727 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: videodermoscopy, lesional capillaroscopy
Description: videodermoscopy and lesional capillaroscopy will be performed under different magnification levels to the skin lesions and data will be recorded.
Study NCT06306586 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Treatment for Adolescents With Eating Disorders
Description: The main aim of the digital treatment is to reduce symptoms of eating disorders and increase life-coping skills. The digital treatment aims to help adolescents with eating disorders to:~* Gain knowledge about the symptoms of eating disorders and the consequences it has on everyday life.~* Be motivated to carry out the treatment.~* Gain knowledge of and skills in regulating food and activity in a more balanced way.~* Gain knowledge of and skills in managing emotions.~* Get tools to develop a better self-esteem.~* Gain awareness of the function of the eating disorder.~* Gain skills in coping with social challenges.~* Get a more realistic image of their bodies and handle information from social media.